Medicare Enrolled
Dr. Ronald Swaab, M.D.
Hematology & Oncology · Pottstown, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Swaab from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Swaab?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Swaab
Dr. Ronald Swaab is a hematology & oncology specialist in Pottstown, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Swaab performed 6,689 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Swaab received a total of $22,214 from 89 pharmaceutical and/or device companies across 1004 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Swaab is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 18% volume in PA
$22,214 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,689
Medicare services
Top 18% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,860 | $19 | $54 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
456 | $8 | $28 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
435 | $8 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $98 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
240 | $12 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
146 | $111 | $352 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
126 | $13 | $52 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $140 | $368 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $136 | $456 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
28 | $54 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $126 | $433 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.6% high complexity
78.1% medium
19.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,214
Total received (2018-2024)
Avg $3,173/year across 7 years
Top 15% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
1,004
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,706
2023
$2,485
2022
$3,760
2021
$2,870
2020
$2,772
2019
$4,981
2018
$3,640
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$146
GlaxoSmithKline, LLC.
$146
Janssen Biotech, Inc.
$145
Daiichi Sankyo Inc.
$136
Astellas Pharma US Inc
$135
Novartis Pharmaceuticals Corporation
$96
GENZYME CORPORATION
$92
ABBVIE INC.
$87
Celgene Corporation
$66
E.R. Squibb & Sons, L.L.C.
$63
Blueprint Medicines Corporation
$58
Karyopharm Therapeutics Inc.
$55
SOBI, INC
$44
Alexion Pharmaceuticals, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$42
Regeneron Healthcare Solutions, Inc.
$42
Incyte Corporation
$42
ADC Therapeutics America, Inc.
$39
JAZZ PHARMACEUTICALS INC.
$29
Merck Sharp & Dohme LLC
$26
Celltrion USA Inc.
$25
PFIZER INC.
$25
Genmab U.S., Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$23
Genentech USA, Inc.
$20
Sumitomo Pharma America, Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
ARRAY BIOPHARMA INC
$17
Top 3 companies account for 25.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,767
Janssen Pharmaceuticals, Inc
$1,579
E.R. Squibb & Sons, L.L.C.
$1,403
Janssen Biotech, Inc.
$1,223
Incyte Corporation
$1,211
Genentech USA, Inc.
$1,066
Celgene Corporation
$850
PFIZER INC.
$755
Daiichi Sankyo Inc.
$724
Novartis Pharmaceuticals Corporation
$681
Amgen Inc.
$672
GENZYME CORPORATION
$655
Seagen Inc.
$590
Lilly USA, LLC
$582
Astellas Pharma US Inc
$501
Merck Sharp & Dohme Corporation
$424
Exelixis Inc.
$409
Pharmacyclics LLC, An AbbVie Company
$340
GlaxoSmithKline, LLC.
$338
EMD Serono, Inc.
$315
Alexion Pharmaceuticals, Inc.
$312
Blueprint Medicines Corporation
$284
Bayer HealthCare Pharmaceuticals Inc.
$284
Karyopharm Therapeutics Inc.
$256
Takeda Pharmaceuticals U.S.A., Inc.
$232
Rigel Pharmaceuticals, Inc.
$213
Eisai Inc.
$209
Regeneron Healthcare Solutions, Inc.
$199
AbbVie, Inc.
$192
AbbVie Inc.
$190
Seattle Genetics, Inc.
$188
Kite Pharma, Inc.
$163
EISAI INC.
$156
Galvanize Therapeutics, Inc
$152
ARRAY BIOPHARMA INC
$150
Kyowa Kirin, Inc.
$149
Dova Pharmaceuticals
$147
Coherus Biosciences Inc.
$133
TESARO, Inc.
$130
ABBVIE INC.
$121
Gilead Sciences, Inc.
$109
Taiho Oncology, Inc.
$108
Puma Biotechnology, Inc.
$108
SANOFI-AVENTIS U.S. LLC
$100
BeiGene USA, Inc.
$95
AVEO Pharmaceuticals, Inc.
$92
Genmab U.S., Inc.
$92
Foundation Medicine, Inc.
$87
Janssen Scientific Affairs, LLC
$83
G1 Therapeutics, Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$67
PharmaEssentia USA Corporation
$67
SOBI, INC
$64
Ipsen Biopharmaceuticals, Inc
$63
Merck Sharp & Dohme LLC
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
ADC Therapeutics America, Inc.
$59
Pharmacyclics LLC, an AbbVie Company
$58
Sobi, Inc
$55
Teva Pharmaceuticals USA, Inc.
$53
JAZZ PHARMACEUTICALS INC.
$50
PUMA BIOTECHNOLOGY, INC.
$46
Pharmacosmos Therapeutics Inc.
$43
Aveo Pharmaceuticals, Inc.
$42
Clovis Oncology, Inc.
$36
TerSera Therapeutics LLC
$35
Secura Bio, Inc.
$29
Prometheus Laboratories Inc.
$27
Fortovia Therapeutics, Inc.
$27
Celltrion USA Inc.
$25
MorphoSys, US Inc.
$25
Lexicon Pharmaceuticals, Inc.
$24
Verastem, Inc.
$24
EUSA Pharma (US) LLC
$23
Global Blood Therapeutics, Inc.
$23
Aurobindo Pharma USA, Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
Spectrum Pharmaceuticals Inc.
$23
Fresenius Kabi USA, LLC
$20
Sumitomo Pharma America, Inc.
$20
Adaptive Biotechnologies Corporation
$19
Stemline Therapeutics Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$16
Apellis Pharmaceuticals, Inc.
$15
Mirati Therapeutics, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Sirtex Medical Inc
$14
AMAG Pharmaceuticals, Inc.
$13
Alnylam Pharmaceuticals Inc.
$12
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
6 · ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALIYA SYSTEM · ALOXI · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · Cresemba · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kabiven · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · Proleukin · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SKYRIZI · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tepmetko · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VIZIMPRO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
96
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
POTTSTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Swaab is a mixed practice specialist, with above-average Medicare volume (top 18% in PA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Swaab experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Swaab performed 4,860 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Swaab receive payments from pharmaceutical companies?
Yes. Dr. Swaab received a total of $22,214 from 89 companies across 1,004 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Swaab's costs compare to other hematology & oncology specialists in Pottstown?
Dr. Swaab's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Swaab) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Pottstown
Browse hematology & oncology specialists in Pottstown ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology